Tag
Strides Pharma Science Limited
2 articles
Strides Sells Pivot Path Majority Stake to Ascent Capital
Strides Pharma board approved sale of majority stake in subsidiary Pivot Path to Ascent Capital consortium for ~Rs. 1,000 million.
Transaction includes Rs. 500 million primary infusion into Pivot Path
Strides Sells Pivot Path Stake to Ascent Capital
Strides Pharma sells 80% stake in subsidiary Pivot Path to Ascent Capital-led consortium for ~₹1,000m, valuing the business at ~₹2,300m post-money.
Transaction includes ₹500m primary capital infusion